SPY423.30+0.19 0.04%
DIA339.46+0.01 0.00%
IXIC14,271.41+18.14 0.13%

Zealand Pharma Posts Wider Q1 Loss; Maintains 2021 Outlook

05/12/2021 05:38

09:27 AM EDT, 05/12/2021 (MT Newswires) -- Zealand Pharma A/S (ZEAL) reported Wednesday a Q1 loss of 5.78 Danish kroner ($0.94) per diluted share, wider than a loss of 4.98 kroner a year ago.

Revenue for the quarter rose to 47.8 million kroner from 12.4 million kroner a year earlier.

The biotechnology company maintained its 2021 outlook of 220 million kroner in net product revenue from the sale of commercial products, plus or minus 10%.

Price: 29.84, Change: -0.38, Percent Change: -1.26